Table 2 Health-related Quality of life scoring of the prostate radiotherapy group over one year
EORTC QLQ-PR25 | Mean (SD) | P-value |
|---|---|---|
Urinary functions Baseline | 76.76 (15.1) | < 0.001* |
3 months | 15.06 (17.32) | |
6 months | 12.02 (15.15) | |
9 months | 12.02 (15.15) | |
12 months | 11.22 (15.17) | |
Incontinence aid Baseline | 14.10 (31.51) | 0.144 |
3 months | 10.26 (26.28) | |
6 months | 11.54 (29.73) | |
9 months | 11.54 (29.73 | |
12 months | 11.54 (29.73) | |
Bowel functions Baseline | 13.78 (10.26) | < 0.001* |
3 months | 10.26 (5.92) | |
6 months | 8.79 (5.74) | |
9 months | 8.33 (5.78) | |
12 months | 8.33 (5.78) | |
ADT-related symptoms Baseline | 57.1 (17.11) | < 0.001* |
3 months | 60.47 (17.87) | |
6 months | 63.03 (17.98) | |
9 months | 64.74 (18.52) | |
12 months | 64.96 (18.51) | |
Sexual activity Baseline | 32.05 (18.81) | < 0.001* |
3 months | 18.27 (14.72) | |
6 months | 16.34 (14.24) | |
9 months | 13.78 (10.53) | |
12 months | 13.46 (10.56) | |
Sexual function Baseline | 14.10 (12.42) | < 0.001* |
3 months | 3.53 (5.86) | |
6 months | 3.53 (5.86) | |
9 months | 3.53 (5.86) | |
12 months | 3.53 (5.86) |